Goldman Sachs’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $958K | Buy |
855,286
+61,900
| +8% | +$69.3K | ﹤0.01% | 3873 |
|
2025
Q1 | $912K | Sell |
793,386
-185,099
| -19% | -$213K | ﹤0.01% | 3864 |
|
2024
Q4 | $5.98M | Sell |
978,485
-280,745
| -22% | -$1.72M | ﹤0.01% | 2720 |
|
2024
Q3 | $20.8M | Sell |
1,259,230
-74,683
| -6% | -$1.24M | ﹤0.01% | 1714 |
|
2024
Q2 | $9.16M | Buy |
1,333,913
+55,294
| +4% | +$380K | ﹤0.01% | 2146 |
|
2024
Q1 | $12.3M | Buy |
1,278,619
+238,110
| +23% | +$2.3M | ﹤0.01% | 1905 |
|
2023
Q4 | $8.65M | Buy |
1,040,509
+583,516
| +128% | +$4.85M | ﹤0.01% | 2197 |
|
2023
Q3 | $3.82M | Sell |
456,993
-215,196
| -32% | -$1.8M | ﹤0.01% | 2667 |
|
2023
Q2 | $6.2M | Buy |
672,189
+278,675
| +71% | +$2.57M | ﹤0.01% | 2409 |
|
2023
Q1 | $5.41M | Buy |
393,514
+194,588
| +98% | +$2.67M | ﹤0.01% | 2482 |
|
2022
Q4 | $3.38M | Sell |
198,926
-50,343
| -20% | -$856K | ﹤0.01% | 2915 |
|
2022
Q3 | $5.67M | Buy |
249,269
+50,715
| +26% | +$1.15M | ﹤0.01% | 2551 |
|
2022
Q2 | $3.58M | Sell |
198,554
-229,533
| -54% | -$4.14M | ﹤0.01% | 2963 |
|
2022
Q1 | $11.4M | Buy |
428,087
+24,463
| +6% | +$654K | ﹤0.01% | 2132 |
|
2021
Q4 | $11.8M | Sell |
403,624
-2,856
| -0.7% | -$83.8K | ﹤0.01% | 2144 |
|
2021
Q3 | $26.7M | Sell |
406,480
-16,403
| -4% | -$1.08M | 0.01% | 1512 |
|
2021
Q2 | $35.2M | Sell |
422,883
-317,427
| -43% | -$26.4M | 0.01% | 1326 |
|
2021
Q1 | $56.8M | Buy |
740,310
+534,992
| +261% | +$41M | 0.01% | 953 |
|
2020
Q4 | $18.1M | Buy |
205,318
+145,264
| +242% | +$12.8M | ﹤0.01% | 1633 |
|
2020
Q3 | $4.43M | Sell |
60,054
-4,591
| -7% | -$339K | ﹤0.01% | 2458 |
|
2020
Q2 | $4.72M | Buy |
+64,645
| New | +$4.72M | ﹤0.01% | 2366 |
|
2019
Q4 | – | Sell |
-54,700
| Closed | -$971K | – | 4331 |
|
2019
Q3 | $971K | Buy |
+54,700
| New | +$971K | ﹤0.01% | 3265 |
|